Creon (pancrelipase) delayed-release capsules

Creon is a prescription pancrelipase medication used as pancreatic enzyme replacement therapy when the pancreas cannot make enough digestive enzymes.

This page explains what the capsules do, how they’re commonly used with meals, and key safety considerations so visitors can prepare for a prescription referral.

US shipping from Canada supports cash-pay access for people without insurance when a valid prescription is provided.

What Creon Is and How It Works

This treatment contains pancrelipase, a mixture of pancreatic enzymes (lipase, protease, and amylase) that help break down fats, proteins, and starches. It’s designed for exocrine pancreatic insufficiency (EPI), where the pancreas does not deliver enough enzymes into the small intestine to digest food. When digestion is incomplete, nutrients may not be absorbed well and stools can become greasy, bulky, or difficult to flush.

Why it matters: Replacing missing enzymes can support digestion and improve nutritional absorption.

These capsules use a delayed-release design with enteric-coated enzyme particles. The coating helps protect enzymes from stomach acid, then allows release in the small intestine where they work best. Prescriptions submitted through the platform are confirmed with the prescriber before dispensing through a licensed Canadian partner pharmacy.

Who It’s For

Pancreatic enzyme replacement is commonly prescribed for EPI related to conditions that affect the pancreas or pancreatic ducts. Many patients first learn about EPI through symptoms, weight changes, vitamin deficiencies, or findings on imaging and lab work. For condition-specific browsing, see the Exocrine Pancreatic Insufficiency hub or related digestive listings in Gastrointestinal.

Common underlying causes include cystic fibrosis, chronic pancreatitis, and pancreatic surgery (including removal of part or all of the pancreas). The Cystic Fibrosis and Chronic Pancreatitis category pages group related therapies and resources. Creon is not appropriate for everyone, including people with hypersensitivity to pancrelipase or pork proteins, since enzymes are typically porcine-derived.

In some situations, enzyme therapy may be paused or avoided during an acute pancreatitis episode until a clinician says it is appropriate. Symptoms such as ongoing abdominal pain, persistent vomiting, or blood in stool warrant prompt clinical assessment, since they can overlap with complications of pancreatic disease. For deeper background, related reading includes the Chronic Pancreatitis Guide and the overview on Pancreas And Diabetes.

Dosage and Usage

Creon is generally taken with meals and snacks so enzymes are present while food is being digested. The prescription is individualized and is usually written in enzyme units per meal, based on factors like age, weight, diet composition, and the cause of pancreatic insufficiency. Because dosing is specific to the patient and diet, the label and prescriber instructions should be followed closely.

Capsules are typically swallowed whole with liquid. They should not be crushed or chewed, since damaging the coating can reduce enzyme activity and may irritate the mouth. When swallowing a capsule is difficult, some prescriptions allow opening the capsule and sprinkling the contents on a small amount of soft acidic food, then swallowing right away without chewing; this should only be done if the official directions for the dispensed product allow it.

Quick tip: Keep doses with food routines to reduce missed-with-meals errors.

If a dose is missed, the next scheduled dose is usually taken with the next meal or snack rather than doubling up. Treatment response is often monitored using symptom patterns, weight trends, and nutrition markers, along with the overall plan for the underlying condition.

Strengths and Forms

Creon is supplied as delayed-release capsules that contain enteric-coated enzyme particles. Strength is commonly expressed by the amount of lipase activity per capsule, because lipase is a key enzyme for fat digestion and fat-soluble vitamin absorption. The prescription will specify the intended capsule strength and the number of capsules to use with meals and snacks.

Packaging and appearance may vary by market and supplier. The dispensing label is the best reference for capsule identification, handling directions, and any specific storage notes from the manufacturer. When comparing prescriptions over time, it helps to confirm the enzyme units and capsule description rather than relying on capsule color alone.

Storage and Travel Basics

Enzymes can be sensitive to heat and moisture. In general, the product is stored at room temperature in the original container, kept tightly closed, and protected from humidity. Avoid storing capsules in places that get hot, such as a parked car, near a stove, or inside a bathroom cabinet with frequent steam.

For travel, carrying capsules in hand luggage can reduce exposure to temperature extremes. If a weekly pill organizer is used, transferring only a short supply may help limit moisture exposure, but the original container should be kept available for identification and expiration details. Any unusual odor, damaged capsules, or concerns about storage conditions should be discussed with a pharmacist before use.

When routines change (vacations, shift work, school schedules), missed-with-meal doses can be more likely. Setting meal-based reminders and keeping a small supply near typical eating locations can help with adherence without altering prescribed directions.

Side Effects and Safety

Like many digestive therapies, side effects can overlap with the underlying condition. Commonly reported effects include stomach or abdominal discomfort, gas, nausea, constipation, diarrhea, or changes in stool pattern. Mouth irritation can occur if capsule contents are chewed or held in the mouth, which is one reason the enteric-coated particles should be swallowed as directed.

Serious reactions are less common but important to recognize. Allergic reactions can include rash, hives, swelling, wheezing, or trouble breathing and require urgent evaluation. A rare complication reported with very high enzyme exposure, especially in pediatric cystic fibrosis populations, is fibrosing colonopathy (scarring and narrowing of the colon), which may present with abdominal pain, persistent constipation, or blood in stool.

Some patients may also have elevated uric acid levels, which matters for people with gout or certain kidney issues. Medication safety questions are reviewed as part of prescription processing through Canadian partner pharmacies that serve U.S. patients via referral pathways.

Drug Interactions and Cautions

Pancrelipase products act locally in the gut, so classic drug–drug interactions are less common than with systemically absorbed medicines. Still, practical interactions can occur through timing and how the capsule is handled. Mixing enzyme particles into non-acidic foods, hot foods, or liquids can damage the enteric coating, which may reduce effectiveness and increase mouth irritation risk.

Cautions are also influenced by the underlying condition. People with a history of intestinal strictures, significant constipation, or prior bowel surgery may need closer monitoring when enzyme doses change. Patients with hyperuricemia (high uric acid) or gout may be monitored more carefully, since enzymes can contain purines. Any sudden change in abdominal symptoms should be evaluated to rule out complications of pancreatic disease rather than assuming it is a medication effect.

When other digestive medicines are part of the regimen (such as acid-suppressing therapies), the prescriber may adjust the overall plan based on symptoms and the type of enzyme product used. A pharmacist can help review the full medication list for handling conflicts and timing issues.

Compare With Alternatives

Several prescription pancreatic enzyme replacement products exist, and they are not always interchangeable capsule-for-capsule. Differences can include enzyme units per capsule, the specific delayed-release design, approved indications, and how instructions address sprinkling on food. If a switch is considered, clinicians typically compare the prescribed lipase units per meal and the patient’s response rather than relying on brand names alone.

One alternative formulation is non–enteric-coated pancrelipase tablets (which may be used with acid suppression because stomach acid can inactivate enzymes). On BorderFreeHealth, the product page for Viokace is a reference point for that non–enteric-coated option. Other approaches may include nutritional changes, treatment of the underlying pancreatic condition, and monitoring for fat-soluble vitamin deficiencies, depending on clinical context.

When comparing options, it helps to track outcomes that matter clinically: stool consistency, frequency of abdominal pain, weight stability, and laboratory markers used by the care team. Any transition plan should be supervised, since under-treatment and over-treatment can both cause problems.

Pricing and Access

Out-of-pocket costs can vary based on capsule strength, total daily enzyme units prescribed, and whether coverage applies. For people paying cash, the total expense often reflects both the dose per meal and the number of meals and snacks per day. The article collection on Gut Health In Aging and Fatty Liver Disease Treatments can provide broader context on digestive health concerns that sometimes coexist with pancreatic disorders.

Access through this platform relies on a valid prescription, and the referral workflow includes coordination with licensed Canadian dispensing partners. Creon may be an option when seeking cash-pay access without insurance, but eligibility and final dispensing depend on prescription verification and clinical appropriateness. When available, Current Promotions may apply to certain cash-pay purchases, subject to terms.

For site actions, prescription details can be uploaded to the account profile and kept updated when the prescriber changes therapy. If refills are needed, the prescriber’s authorization remains the controlling requirement, and the pharmacy team may request clarification to match the written directions.

Authoritative Sources

For the most accurate and current details, checking official prescribing information and trusted clinical references is helpful. These sources describe approved uses, warnings, and handling instructions, and they are especially important when symptoms change or when other conditions (such as kidney disease or gout) are part of the health picture.

The links below are reference materials commonly used by clinicians and pharmacists. They can support informed conversations with a healthcare professional about enzyme therapy, diet considerations, and monitoring plans. Labeling can differ across countries, so the dispensed product leaflet should also be reviewed.

• FDA prescribing information reference: FDA Pancrelipase Product Overview
• Medication overview and safety notes: MedlinePlus Pancrelipase Information
• Background on pancreatic enzymes in CF care: Cystic Fibrosis Foundation Pancreatic Enzymes

To continue through the site, add the prescription information and select prompt, express shipping at checkout.

This content is for informational purposes only and is not a substitute for professional medical advice.